| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/16/1993 | US5194596 Production of vascular endothelial cell growth factor |
| 03/16/1993 | US5194440 Treatment for migraine; selective agonist |
| 03/16/1993 | US5194437 Substituted with oxygen containing heterocycle, central nervous system disorders, neuroendocrine disorders |
| 03/16/1993 | US5194430 Heterocyclic-nmda antagonists |
| 03/16/1993 | CA1314655C Hydroxylamine derivatives |
| 03/16/1993 | CA1314553C Bicyclic compounds, processes for preparation thereof and pharmaceutical composition comprising the same |
| 03/16/1993 | CA1314545C Non-peptidic renin inhibitors |
| 03/16/1993 | CA1314485C Pharmaceutical composition for piperidinoalkanol-decongestant combination |
| 03/14/1993 | CA2077922A1 Substituted amide derivatives of piperizinylcamphorsulfonyl oxytocin antagonists |
| 03/11/1993 | CA2077967A1 N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present |
| 03/10/1993 | EP0531119A1 N,N',N'-trisubstituted -5-bis-aminomethylene-1,3-dioxane-4,6-dione inhibitors of acyl-CoA: cholesterol-acyl transferase |
| 03/10/1993 | EP0531078A1 (R)-3-Methoxy-4- 1-methyl-5-(2-methyl-4,4,4-trifluorobutylcarbamoyl)indol-3-ylmethyl -N-(2-methylsulphonyl)benzamide in crystalline form |
| 03/10/1993 | EP0531026A1 Hexahydrobenzo[f]quinolinones as 5-alpha-reductase inhibitors |
| 03/10/1993 | EP0530980A1 Neristatin 1 and a composition comprising the compound for the treatment of lymphocytic leukemia |
| 03/10/1993 | EP0530804A1 Kits and compositions for the treatment and repair of defects or lesions in cartilage or bone |
| 03/10/1993 | EP0530702A1 1,2-dihydro-2-oxopyridines as angiotensin II antagonists |
| 03/10/1993 | EP0530639A1 Quinolylmethoxy-phenylacetamides substituted by a heterocycle as lipoxygenase inhibitors |
| 03/10/1993 | EP0530614A1 Novel antisense oligonucleotider with continuous phosphoramidate internucleotide linkage |
| 03/10/1993 | EP0530505A2 Hydantoin derivatives |
| 03/10/1993 | EP0530353A1 New imidazopyridines as serotonergic 5-ht 3? antagonists |
| 03/10/1993 | EP0530268A1 Process for the preparation of 7-alpha-alkoxycephem derivatives. |
| 03/10/1993 | EP0530265A1 Dna encoding human 5-ht 1d? receptors and uses thereof |
| 03/10/1993 | CN1069733A 6-Oxo-azepinoindole and process for producing same and intermediate and application as pharmaceutical |
| 03/10/1993 | CN1069731A Dibenz |b,f¨ |1,4¨ oxazepin-11(10H)-ones for multidrug resistance reversing agents |
| 03/10/1993 | CN1069726A Medicaments |
| 03/10/1993 | CA2077732A1 Heterocyclic derivatives |
| 03/09/1993 | US5192775 New aminomethylpiperidine compounds |
| 03/09/1993 | US5192746 Cyclic cell adhesion modulation compounds |
| 03/09/1993 | CA1314290C Hydroxamic acids of 7-oxabicycloheptane substituted ethers |
| 03/09/1993 | CA1314283C Pyrazine diazohydroxide compounds and methods for their production and use |
| 03/09/1993 | CA1314233C Calcium supplements |
| 03/09/1993 | CA1314223C Composition for treating gastrointestinal disorders |
| 03/09/1993 | CA1314218C Remote administration of hyaluronic acid to mammals |
| 03/09/1993 | CA1314211C Agent for reducing nephrotoxicity caused by cyclosporin administration |
| 03/07/1993 | CA2077465A1 Heterocyclically substituted quinolylmethoxy-phenylacetamides |
| 03/06/1993 | CA2076722A1 Pharmaceutical agents |
| 03/05/1993 | CA2077412A1 1,2-dihydro-2-oxopyridines |
| 03/04/1993 | WO1993004373A1 Calcium receptor active molecules |
| 03/04/1993 | WO1993004052A1 Amide tetrazole acat inhibitors |
| 03/04/1993 | WO1993004046A1 Angiotensin ii receptor blocking imidazolinone derivatives |
| 03/04/1993 | WO1993004040A1 Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
| 03/04/1993 | WO1993003768A1 Isolation, growth, differentiation and genetic engineering of human muscle cells |
| 03/04/1993 | WO1993003730A1 Protein kinase c inhibition and novel compound balanol |
| 03/04/1993 | WO1993003726A1 Muscarinic agonists |
| 03/04/1993 | WO1993003725A1 5-ht4 receptor antagonists |
| 03/04/1993 | WO1993003723A1 Leukotriene receptor antagonist-antihistamine complex |
| 03/04/1993 | WO1993003713A1 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones |
| 03/04/1993 | WO1993003709A1 Composition and method for treating cystic fibrosis |
| 03/04/1993 | WO1993000330A3 Azanorbornane derivatives |
| 03/04/1993 | WO1993000313A3 Sigma receptor ligands and the use thereof |
| 03/04/1993 | WO1993000094A3 Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine |
| 03/04/1993 | WO1992020796A3 D-type cyclin and uses related thereto |
| 03/04/1993 | WO1992018160A3 Method for inhibiting adhesion of white blood cells to endothelial cells |
| 03/04/1993 | WO1992018089A3 Use of steroidal and non-steroidal amines to sensitize multidrug-resistant cells |
| 03/04/1993 | CA2116118A1 Isolation, growth, differentiation and genetic engineering of human muscle cells |
| 03/04/1993 | CA2116024A1 5-ht4 receptor antagonists |
| 03/04/1993 | CA2115994A1 Protein kinase c inhibition and novel compound balanol |
| 03/04/1993 | CA2115990A1 Angiotensin ii receptor blocking imidazolinone derivatives |
| 03/04/1993 | CA2115364A1 Composition and method for treating cystic fibrosis |
| 03/04/1993 | CA2114945A1 Leukotriene receptor antagonist-antihistamine complex |
| 03/04/1993 | CA2112397A1 Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
| 03/04/1993 | CA2077314A1 Antisense oligonucleotides with phosphoramidate internucleotide linkage throughout |
| 03/03/1993 | EP0530166A2 3-Hydroxy anthranilic acid derivatives for inhibiting 3-hydroxy anthranilate oxygenase |
| 03/03/1993 | EP0529898A1 Potentiation of the antitussive effect of dextromethorphan with acetaminophen (paracetamol) |
| 03/03/1993 | EP0529854A2 Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as HMG-COA reductase inhibitors |
| 03/03/1993 | EP0529499A1 Compositions for topical administration to the nose or the eyes containing bradykinin antagonists |
| 03/03/1993 | EP0529386A1 Dibenz[B,F][1,4]oxazepin-11(10H)-ones for multidrug resistance reversing agents |
| 03/03/1993 | EP0529253A1 Phenylalkylderivatives, compounds containing them and process for their fabrication |
| 03/03/1993 | EP0528957A1 Five-membered ring alkanoic acid leukotriene antagonists |
| 03/03/1993 | EP0528949A1 An apparatus for preparing a concentrate of coagulation factors, such as fibrinogen, from a blood sample. |
| 03/03/1993 | EP0528926A1 Soluble peptide analogues containing binding sites |
| 03/03/1993 | EP0528891A1 Method for increasing blood-brain barrier permeability |
| 03/03/1993 | EP0211013B1 Immunotherapeutic methods and compositions employing antigenes characteristic of malignant neoplasms |
| 03/03/1993 | CN1069488A HexahydrobenzoÛFÙ quinolinones |
| 03/02/1993 | US5191067 For treatment of fibroblast growth factor mediated pathophysiological conditions |
| 03/02/1993 | US5190938 Elastase inhibitors, treatment of cystic fibrosis, atherosclerosis, rheumatic diseases |
| 03/02/1993 | US5190937 Lactam derivatives |
| 03/02/1993 | CA1314048C Quinolinylmethoxyphenylsulfonyl-carboxamides as anti-inflammatory/antiallergic agents |
| 03/02/1993 | CA1314042C Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents |
| 02/24/1993 | EP0528661A2 HIV protease inhibitors with N-terminal polyether substituents |
| 02/24/1993 | EP0528587A1 Inhibiting osteoclast-mediated bone resorption using substituted phenyl derivatives |
| 02/24/1993 | EP0528586A1 Inhibiting osteoclast-mediated bone resorption using aminoalkyl-substituted phenyl derivatives |
| 02/24/1993 | EP0528495A1 Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
| 02/24/1993 | EP0528485A1 17Beta-acyl-3-androsta-3,5-dienes as testosterone 5alpha-reductase inhibitors |
| 02/24/1993 | EP0528468A1 Use of triclosan for the manufacture of a medicament for inhibiting cyclooxygenase |
| 02/24/1993 | EP0527917A1 Use of adenosine and adenosine derivatives for anesthesia |
| 02/24/1993 | EP0527818A1 Oligonucleotide modulation of arachidonic acid metabolism |
| 02/24/1993 | EP0527801A1 Thiophene sulfonamides useful as carbonic anydrase inhibitors |
| 02/24/1993 | EP0527783A1 Method of treatment with hsp70 |
| 02/24/1993 | EP0527764A1 Phosphonopeptides with collagenase inhibiting activity |
| 02/24/1993 | EP0527761A1 Phosphonopeptides with collagenase inhibiting activity |
| 02/23/1993 | US5189212 Used in estrogen replacement therapy like menopause, osteoporosis therapy, prevention of excessive hair growth of body and infertility |
| 02/23/1993 | US5189179 Serotonin 5ht1a agonists |
| 02/23/1993 | US5189178 Preventing protein destruction |
| 02/23/1993 | US5189148 Fibroblast growth factor; mixture with water insoluble hydroxypropyl cellulose |
| 02/23/1993 | US5189049 Heterocyclic substituted acylaminothiazoles, their preparation and pharmaceutical compositions containing them |
| 02/23/1993 | US5189045 Antiserotonine agent |
| 02/23/1993 | US5189033 Analgesics, antiiflammatory agents |
| 02/23/1993 | US5189031 Urea derivatives, compositions and use |
| 02/23/1993 | US5188839 Pharmaceutical compositions of cimetidine |